Here’s what you should know.
1. Boston Scientific is going to $8-a-share for all of EndoChoice’s outstanding shares.
2. Its expected the deal will close in the fourth quarter. EndoChoice will then become part of Boston Scientific’s endoscopy business.
3. EndoChoice had $75 million in sales for 12 months on June 30.
More GI/endoscopy news:
Nanticoke Physician Network adds Dr. Ismet Lukolic: 4 things to know
Takeda named in Working Mother’s top companies: 3 notes
GI physician Dr. Christopher Meyer out as Holzer Health System CEO: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.